Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,011 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatocellular organellar abnormalities following elimination of hepatitis C virus.
Aoyagi H, Iijima H, Gaber ES, Zaitsu T, Matsuda M, Wakae K, Watashi K, Suzuki R, Masaki T, Kahn J, Saito T, El-Kassas M, Shimada N, Kato K, Enomoto M, Hayashi K, Tsubota A, Mimata A, Sakamaki Y, Ichinose S, Muramatsu M, Wake K, Wakita T, Aizaki H. Aoyagi H, et al. Among authors: enomoto m. Liver Int. 2023 Aug;43(8):1677-1690. doi: 10.1111/liv.15624. Epub 2023 Jun 13. Liver Int. 2023. PMID: 37312620
Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients.
Kobayashi S, Takeda T, Enomoto M, Tamori A, Kawada N, Habu D, Sakaguchi H, Kuroda T, Kioka K, Kim SR, Kanno T, Ueda T, Hirano M, Fujimoto S, Jomura H, Nishiguchi S, Seki S. Kobayashi S, et al. Among authors: enomoto m. Liver Int. 2007 Mar;27(2):186-91. doi: 10.1111/j.1478-3231.2006.01406.x. Liver Int. 2007. PMID: 17311612
A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C.
Atsukawa M, Tsubota A, Kondo C, Uchida-Kobayashi S, Takaguchi K, Tsutsui A, Nozaki A, Chuma M, Hidaka I, Ishikawa T, Iwasa M, Tamai Y, Tobari M, Matsuura K, Nagura Y, Abe H, Kato K, Suzuki K, Okubo T, Arai T, Itokawa N, Toyoda H, Enomoto M, Tamori A, Tanaka Y, Kawada N, Takei Y, Iwakiri K. Atsukawa M, et al. Among authors: enomoto m. PLoS One. 2021 Sep 10;16(9):e0257166. doi: 10.1371/journal.pone.0257166. eCollection 2021. PLoS One. 2021. PMID: 34506563 Free PMC article.
On-treatment gamma-glutamyl transferase predicts the development of hepatocellular carcinoma in chronic hepatitis B patients.
Huang CF, Jang TY, Jun DW, Ahn SB, An J, Enomoto M, Takahashi H, Ogawa E, Yoon E, Jeong SW, Shim JJ, Jeong JY, Kim SE, Oh H, Kim HS, Cho YK, Kozuka R, Inoue K, Cheung KS, Mak LY, Huang JF, Dai CY, Yuen MF, Nguyen MH, Yu ML. Huang CF, et al. Among authors: enomoto m. Liver Int. 2022 Jan;42(1):59-68. doi: 10.1111/liv.15085. Epub 2021 Nov 29. Liver Int. 2022. PMID: 34687130 Clinical Trial.
Global treatment rate and barriers to direct-acting antiviral therapy: A systematic review and meta-analysis of 146 studies and 1 760 352 hepatitis C virus patients.
Nguyen VH, Huang DQ, Le MH, Jin M, Lee EY, Henry L, Nerurkar SN, Ogawa E, Thin KN, Teng MLP, Goh KS, Kai JCY, Wong C, Tan DJH, Thuy LTT, Hai H, Enomoto M, Cheung R, Nguyen MH. Nguyen VH, et al. Among authors: enomoto m. Liver Int. 2023 Jun;43(6):1195-1203. doi: 10.1111/liv.15550. Epub 2023 Mar 8. Liver Int. 2023. PMID: 36825358
Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence.
Qin XY, Shirakami Y, Honda M, Yeh SH, Numata K, Lai YY, Li CL, Wei F, Xu Y, Imai K, Takai K, Chuma M, Komatsu N, Furutani Y, Gailhouste L, Aikata H, Chayama K, Enomoto M, Tateishi R, Kawaguchi K, Yamashita T, Kaneko S, Nagaoka K, Tanaka M, Sasaki Y, Tanaka Y, Baba H, Miura K, Ochi S, Masaki T, Kojima S, Matsuura T, Shimizu M, Chen PJ, Moriwaki H, Suzuki H. Qin XY, et al. Among authors: enomoto m. Int J Cancer. 2024 Aug 1;155(3):582-594. doi: 10.1002/ijc.34893. Epub 2024 Feb 21. Int J Cancer. 2024. PMID: 38380807
Emerging antiviral drugs for hepatitis C virus.
Enomoto M, Tamori A, Kawada N. Enomoto M, et al. Rev Recent Clin Trials. 2009 Sep;4(3):179-84. doi: 10.2174/157488709789957628. Rev Recent Clin Trials. 2009. PMID: 20028330 Review.
1,011 results